You know that old cliché saying “the only thing that is constant is change”? It seems more and more appropriate. We live in a world where we are connected to news, information, ideas … and work almost 24/7.
On the world stage, we are seeing major political shifts from Brexit in Europe to Saudi Arabia’s regulatory reforms in the Middle East and a seemingly growing political divide here in the United States. In the life sciences sector, we continue to see ever-increasing technological advancements and the struggle around ethical boundaries to how science should be applied. In our industry, we are nearing the end of the merger and acquisition phase for the Big 6, now the Big 3 (Bayer, Corteva Agriscience and Syngenta), and companies are fighting for everything they have, from genetics to market share.